Grants and Contributions

This Priority Announcement (PA) is led by the Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Cystic Fibrosis Canada.
The CIHR-ICRH has the broad mandate of supporting research on the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep.
Cystic Fibrosis Canada has the mandate to act boldly for all Canadians living with cystic fibrosis so they can live longer, healthier, fuller lives.
This PA is focused the management of cystic fibrosis (CF) across the lifespan, including, but not limited to, data acquisition.
• The proposed research should inform the management of cystic fibrosis.
• The proposed research should consider and/or include more than one (1) developmental or intergenerational period over the lifespan. Examples include, but are not limited to:
o one developmental period such as before and after puberty or before and after age 18, or
o different developmental periods across generations (e.g. biological parent and fetus or offspring), or
o two (2) developmental periods in females related to puberty, child-bearing age and menopause.

For the purpose of this PA:
• Only research on the management of CF related symptoms and conditions which also fall into ICRH’s mandate will be considered.
Examples of eligible projects include, but are not limited to:
• Understanding the changing health issues of individuals with CF as they age
• Understanding the long-term effects of medications (including CF transmembrane conductance regulators (CFTR) modulators) in CF over the lifespan
• Understanding the impact of modulators on fetal development and early childhood
• Understanding changes in treatments as people with CF age
• Strategies to maintain and enhance lung health over the lifespan
• Transitions from pediatric to adult CF care
• Preventative strategies for cardiovascular and other complications

This award was established to recognize the excellence of cancer research being conducted in Canada. This award will be given annually to the highest-ranking Early Career Researchers in the Project Grant competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:
• ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

CIHR is committed to leverage the power of research to accelerate global health equity for all. The CIHR Framework for Action on Global Health Research 2021-2026 recognizes that CIHR must work globally because today’s most pressing health problems, and many of the most effective strategies to prevent, contain, and address them, are global. In alignment with this Framework, this priority announcement aims to grow global health research capacity and excellence.
Funding will be provided for applications that have a primary focus on global health research (as per CIHR’s definition) and that are relevant to one of the mandates below:
• Institute of Population and Public Health (IPPH)
• Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE)

The specific objective of this funding opportunity is to:

• Catalyze and support research efforts of Canadian researchers to use the available CLSA data to better understand how biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact on both maintaining health and the development of disease and disability as people age.

The specific objective of this funding opportunity is to:

• Catalyze and support research efforts of Canadian researchers to use the available CLSA data to better understand how biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact on both maintaining health and the development of disease and disability as people age.

This Priority Announcement (PA) is led by the Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with the Canadian Allergy, Asthma and Immunology foundation (CAAIF).

The CIHR-ICRH has the broad mandate of supporting research on the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep.

CAAIF has the mission to invest in high-quality Canadian research to better prevent and treat allergy, asthma and immunologic diseases.

This PA is focused on acute asthma care across the lifespan, including, but not limited to, data acquisition.
• The proposed research should inform the management of acute asthma care, including, but not limited to, the use of inhalers.
• The proposed research should consider and/or include more than one (1) developmental or intergenerational period over the lifespan. Examples include, but are not limited to:
• one developmental period such as before and after puberty or before and after age 18, or
• different developmental periods across generations (e.g. biological parent and fetus or offspring), or
• two (2) developmental periods in females related to puberty, child-bearing age and menopause.

For the purpose of this PA:

• Acute asthma care includes assessment and diagnosis, management and control of symptoms, monitoring and supportive care, preventative measures such as management of triggers and risk factors, patient education and intensive care.

The specific objective of this funding opportunity is to:

• Provide funding to develop and implement an intensive capacity-building program for forty trainees in targeted strategic areas.

The CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund an application that is determined to be relevant to their mandate and research priority areas:¿

• INMHA supports research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.¿

The CIHR Institute for Population and Public Health (CIHR-IPPH) will fund applications that are relevant to their mandate, relevant to CIHR’s definition of population health research (pillar 4 research), focused on meaningfully improving health equity* and aligned with one or more of the following IPPH strategic research areas:
• Healthy Cities: applications aligned with CIHR's Healthy Cities Research Initiative (HCRI) and focused on population health intervention research and/or implementation science as it relates to urban environments.
• Public Health Systems: applications that identify and/or address key public health systems research priorities in Canada.
• Moving Upstream: applications with a primary focus on interdisciplinary research into the structural determinants of health to meaningfully address the root causes and systems that create health inequities in Canada and globally.

The CIHR Institute of Neurosciences, Mental Health and Addiction (CIHR-INMHA) will fund an application that is determined to be relevant to their mandate and research priority areas:¿

• INMHA supports research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.¿